MALACHITE INNOVATIONS LAUNCHES NEW BUSINESS FOCUSED ON MITIGATION BANKING TO RESTORE ENVIRONMENTALLY DEGRADED STREAMS AND WETLANDS
December 20, 2022 18:48 ET
|
Malachite Innovations, Inc.
CLEVELAND, OHIO, Dec. 20, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”), a public company focused on improving the health and wellness of people and the planet,...
MALACHITE INNOVATIONS LAUNCHES TERRA PRETA, A NEW BUSINESS FOCUSED ON PRODUCING BIOCHAR FOR AGRICULTURAL AND WATER FILTRATION MARKETS
December 15, 2022 09:15 ET
|
Malachite Innovations, Inc.
CLEVELAND, OHIO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”), a public company focused on improving the health and wellness of people and the planet,...
MALACHITE INNOVATIONS LAUNCHES NEW BUSINESS FOCUSED ON PROVIDING ECO-FRIENDLY, TECHNOLOGY-DRIVEN SECURITY SERVICES TO ACTIVE AND FORMER MINE SITES USING MILITARY VETERANS AND FIRST RESPONDERS
November 29, 2022 09:15 ET
|
Malachite Innovations, Inc.
CLEVELAND, OHIO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”), a public company focused on improving the health and wellness of people and the planet,...
MALACHITE INNOVATIONS ANNOUNCES SIGNED LETTER OF INTENT WITH RANGE ENVIRONMENTAL RESOURCES, INC.
March 15, 2022 16:05 ET
|
Malachite Innovations, Inc.
CLEVELAND, OHIO, March 15, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”) announces that it has entered into a non-binding letter of intent (the “Letter of...
Vitality Biopharma Enters Into $5 Million Equity Line Financing Relationship With Institutional Investor
August 20, 2021 09:00 ET
|
Vitality Biopharma, Inc
CLEVELAND, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the therapeutic...
Vitality Biopharma Board Update
April 27, 2020 16:52 ET
|
Vitality Biopharma, Inc
CLEVELAND, April 27, 2020 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (Ticker: VBIO) (“Vitality Biopharma,” “Vitality,” or the “Company”), a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Welcomes New Executive Management Team
May 14, 2019 09:00 ET
|
Vitality Biopharma, Inc
– Appointment of Current Director Michael Cavanaugh as Interim Chief Executive Officer –– Promotion of Current Controller and Counsel Richard McKilligan to Chief Financial Officer – LOS ANGELES, May ...
Vitality Biopharma Announces Corporate Updates and Completion of an SEC Examination
November 21, 2018 07:00 ET
|
Vitality Biopharma, Inc
Company appoints two new directors including the Hon. Edward Feighan as new Chairman of the Board LOS ANGELES, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO)...